Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04343885
Title In Men With Metastatic Prostate Cancer, What is the Safety and Benefit of Lutetium-177 PSMA Radionuclide Treatment in Addition to Chemotherapy (UpFrontPSMA)
Acronym UpFrontPSMA
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Peter MacCallum Cancer Centre, Australia
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
Liverpool Hospital Liverpool New South Wales 2170 Australia Details
Royal North Shore St Leonards New South Wales 2065 Australia Details
St Vincent's Hospital Sydney Sydney New South Wales 2010 Australia Details
Chris O'Brien Lifehouse Sydney New South Wales 2050 Australia Details
Royal Brisbane and Women's Hospital Brisbane Queensland 4029 Australia Details
Royal Adelaide Hospital Adelaide South Australia 5000 Australia Details
Cabrini Hospital Malvern Victoria 3144 Australia Details
Peter MacCallum Cancer Centre Melbourne Victoria 3000 Australia Details
Austin Health Melbourne Victoria 3084 Australia Details
Alfred Hospital Prahran Victoria 3000 Australia Details
Fiona Stanley Hospital Murdoch Western Australia 6150 Australia Details
Sir Charles Gairdner Hospital Nedlands Western Australia 6009 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field